Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regression Discontinuity Designs to Evaluate Real-world Effectiveness: a Case Study of Drotrecogin Alpha

NCT02843685 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT02843685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regression Discontinuity Designs to Evaluate Real-world Effectiveness: a Case Study of Drotrecogin Alpha
Lead sponsor
Boston Medical Center
Phase
Observational
Overall status
Completed
Start date
December 31, 2002
Completion date
Not reported
Enrollment
12,492 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis